These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36376343)

  • 41. Antibiotic resistance in gram-negative bacilli: a Singapore perspective.
    Tan TY; Hsu LY; Koh TH; Ng LS; Tee NW; Krishnan P; Lin RT; Jureen R
    Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 43. Carbapenemase-Producing Gram-Negative Bacteria in Andalusia, Spain, 2014-2018.
    López-Hernández I; Delgado-Valverde M; Fernández-Cuenca F; López-Cerero L; Machuca J; Pascual Á
    Emerg Infect Dis; 2020 Sep; 26(9):2218-2222. PubMed ID: 32818413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.
    Landman D; Bratu S; Kochar S; Panwar M; Trehan M; Doymaz M; Quale J
    J Antimicrob Chemother; 2007 Jul; 60(1):78-82. PubMed ID: 17490999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phytantriol-Based Cubosome Formulation as an Antimicrobial against Lipopolysaccharide-Deficient Gram-Negative Bacteria.
    Lai X; Ding Y; Wu CM; Chen X; Jiang JH; Hsu HY; Wang Y; Le Brun AP; Song J; Han ML; Li J; Shen HH
    ACS Appl Mater Interfaces; 2020 Oct; 12(40):44485-44498. PubMed ID: 32942850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
    Yarlagadda V; Manjunath GB; Sarkar P; Akkapeddi P; Paramanandham K; Shome BR; Ravikumar R; Haldar J
    ACS Infect Dis; 2016 Feb; 2(2):132-9. PubMed ID: 27624964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report.
    Veeraraghavan B; Jesudason MR; Prakasah JAJ; Anandan S; Sahni RD; Pragasam AK; Bakthavatchalam YD; Selvakumar RJ; Dhole TN; Rodrigues C; Roy I; Joshi S; Chaudhuri BN; Chitnis DS
    Indian J Med Microbiol; 2018; 36(1):32-36. PubMed ID: 29735823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.
    Escobar-Salom M; Torrens G; Jordana-Lluch E; Oliver A; Juan C
    Biol Rev Camb Philos Soc; 2022 Jun; 97(3):1005-1037. PubMed ID: 35043558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes.
    Manandhar S; Zellweger RM; Maharjan N; Dongol S; Prajapati KG; Thwaites G; Basnyat B; Dixit SM; Baker S; Karkey A
    Ann Clin Microbiol Antimicrob; 2020 Oct; 19(1):48. PubMed ID: 33087115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals.
    Lõivukene K; Kermes K; Sepp E; Adamson V; Mitt P; Jürna M; Mägi H; Kallandi U; Otter K; Naaber P
    Antonie Van Leeuwenhoek; 2006; 89(3-4):367-71. PubMed ID: 16779633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program.
    Al Rahmany D; Albeloushi A; Alreesi I; Alzaabi A; Alreesi M; Pontiggia L; Ghazi IM
    Int J Infect Dis; 2019 Jun; 83():77-82. PubMed ID: 30959249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distribution of Antimicrobial Resistance and Virulence Genes within the Prophage-Associated Regions in Nosocomial Pathogens.
    Kondo K; Kawano M; Sugai M
    mSphere; 2021 Aug; 6(4):e0045221. PubMed ID: 34232073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic, genotypic, and metabolic resistance mechanisms of ESKAPE bacteria to chemical disinfectants: a systematic review and meta-analysis.
    Chegene Lorestani R; Shojaeian A; Rostamian M
    Expert Rev Anti Infect Ther; 2023; 21(10):1097-1123. PubMed ID: 37674347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L
    Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
    Bluhm ME; Knappe D; Hoffmann R
    Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.